Successfully Managing Your Neuropathic Pain Therapy Study
Neuropathic pain is pain that arises from damage to the nervous system. It poses challenges that are distinct from those associated with nociceptive pain. In many people living with neuropathic pain, there is no physical or outwardly addressable injury. It’s chronic lower back pain or pain arising from multiple sclerosis, cancer, fibromyalgia, or diabetes. For others, it’s the phantom pain associated with an amputated limb.
If you’re working on a therapy targeted at neuropathic pain, you face a range of challenges. You may need to source your clinical trial participants obliquely – looking for people with diabetes and pain, MS and pain, and so on. You may need to conduct novel trials in order to avoid the ethical conflicts that might arise in a traditional placebo-controlled trial because you cannot ask people suffering from one condition to forego their medications while you track the impact of the pain medication you are testing.
None of this is likely your area of expertise, either. But it is our area of expertise. Worldwide Clinical Trials is an award-winning, internationally recognized leader in the area of clinical trial management. We offer full-service Phase I–Phase IV trial support, as well as real-world evidence clinical research services (which can be particularly important when tracking medications that could become addictive). With more than 30 years of experience in the realm of clinical trials and broad CNS research, Worldwide is uniquely positioned to help you bring a neuropathic pain therapy through the rigors of clinical trials and on to the broader populations of patients who are eager to see if your approach will alleviate the pain they experience. Work with a tenacious CRO that never gives up on the therapy you’ve worked so hard to develop.